Encompass More Asset Management’s Novo Nordisk NVO Stock Holding History

Encompass More Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,976	Closed	-$202K	–	281
2025 Q4	$202K	Sell	3,976 -905	-19%	-$46.3K	0.04%	232
2025 Q3	$271K	Buy	4,881 +1,057	+28%	+$61.9K	0.05%	193
2025 Q2	$264K	Sell	3,824 -340	-8%	-$23.1K	0.06%	173
2025 Q1	$289K	Buy	4,164 +767	+23%	+$63.3K	0.09%	154
2024 Q4	$292K	Buy	3,397 +1,128	+50%	+$122K	0.1%	152
2024 Q3	$270K	Buy	2,269 +285	+14%	+$38K	0.1%	148
2024 Q2	$283K	Buy	1,984 +47	+2%	+$6.23K	0.2%	75
2024 Q1	$249K	Sell	1,937 -216	-10%	-$25.7K	0.21%	78
2023 Q4	$223K	Buy	+2,153	New	+$213K	0.25%	82

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Encompass More Asset Management's NVO Position: Q1 2026 in Review

Encompass More Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 3,976 shares — an estimated $202K sold.

Encompass More Asset Management first reported a position in NVO in Q4 2023 and held it in 9 quarters. The position peaked at $292K in Q4 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Encompass More Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Encompass More Asset Management sold 3,976 Novo Nordisk shares in Q1 2026, an estimated $202K.
Encompass More Asset Management first reported a position in Novo Nordisk in Q4 2023 and held it in 9 quarters.
Encompass More Asset Management's Novo Nordisk position peaked at $292K in Q4 2024.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Encompass More Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.